About Vanina de Verneuil
Vanina de Verneuil is EVP, General Counsel, Corp Sec at Vir Biotechnology.
Form D filings name Vanina de Verneuil as an executive officer at Encentrio Therapeutics.
Vanina de Verneuil reports to the SEC as an officer of 1 public company.
Vanina de Verneuil first appears on SEC filings in 2023.
Experience
This experience comes from SEC filings. The years are when the filings name Vanina de Verneuil in the role, so the role may have started earlier or lasted longer.
VI
Vir Biotechnology, Inc.
EVP, General Counsel, Corp Sec
2024 – 2026 · Public company (VIR)
Key Colleagues at Startups
The people Vanina de Verneuil works with at each company, as listed on that company's latest Form D.
Encentrio Therapeutics, Inc. · Form D, Apr 3, 2023
TH
Thomas Hecht
Director
GS
George Scangos
Director
SL
Sung Lee
Executive officer and director
JN
Johanna Friedl-Naderer
Director
NS
Natascha Schill
Chief Executive Officer and director